Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies

Samantha Johnstone; Maryam Sorkhou; Molly Zhang; Sarah S Dermody; Rachel A Rabin; Tony P George

doi:10.1080/00952990.2023.2292010

Cannabis cravings predict cigarette use in schizophrenia: a secondary analysis from two cannabis abstinence studies

Am J Drug Alcohol Abuse. 2024 Jan 2;50(1):95-105. doi: 10.1080/00952990.2023.2292010. Epub 2024 Jan 12.

Authors

Samantha Johnstone¹, Maryam Sorkhou^{1

2}, Molly Zhang^{1

2}, Sarah S Dermody³, Rachel A Rabin⁴, Tony P George^{1

2

5}

Affiliations

¹ Addictions Division and Centre for Complex Interventions (CCI), Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
² Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
³ Department of Psychology, Toronto Metropolitan University, Toronto, ON, Canada.
⁴ Department of Psychiatry, McGill University and Douglas Mental Health University Institute, Montreal, QC, Canada.
⁵ Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

PMID: 38214479
DOI: 10.1080/00952990.2023.2292010

Abstract

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in SchizophreniaURL: www.clinicaltrials.gov; Registration Number: NCT03189810.

Keywords: Cannabis; abstinence; cigarette; craving; schizophrenia; smoking; tobacco.

MeSH terms

Cannabis*
Clinical Trials as Topic
Craving / physiology
Humans
Prefrontal Cortex / physiology
Schizophrenia*
Tobacco Products*
Transcranial Magnetic Stimulation

Associated data

ClinicalTrials.gov/NCT03189810